Skip to main content

Please wait ...

Phil Wolfson, MD


Phil Wolfson, MD, is president and CEO of the non-profit Ketamine Research Foundation and directs the training of KAP practitioners through The Ketamine Center. Phil’s book, The Ketamine Papers, is the seminal work in the burgeoning ketamine arena. He is principal investigator for the MAPS sponsored Phase 2, the FDA-approved 18-person study of MDMA-Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine-Assisted Psychotherapy.

Speaker Disclosures:
Financial: Philip Wolfson is the founder and CEO of The Ketamine Research Foundation. He has an ownership interest in Progressive Therapeutics, Inc. Dr. Wolfson will address off-label uses. He has no relevant financial relationships with ineligible organizations.
Non-financial: Philip Wolfson has no relevant non-financial relationship to disclose.

Psychedelics in Therapy

MDMA, Psilocybin, Ketamine, Micro-Dosing, & More

Speakers:
Elizabeth Nielson, PhD |  Ingmar Gorman, PhD |  Seema Desai, MD |  Jeffrey Guss, MD |  Gabor Maté, MD |  Matthew W. Johnson, PhD |  Victor Cabral, MSW, LSW, CCTP-I |  Phil Wolfson, MD |  ....
Copyright:
Aug 25, 2023
Media Type:
Online Course
Price:
£149.99 Normal Price: Standard - £545.92

The Fantastic Effects of Ketamine Assisted Psychotherapy: A Revolution in Clinical Practice


Speakers:
Phil Wolfson, MD
Format:
Audio and Video
Copyright:
Jul 28, 2022
Media Type:
Digital Recording
Price:
£49.99 - Standard

Showing 1 to 5 of 6 entries